Bathi sadurunge mbayar bunga, pajak, lan amortisasi: bauschhealth.com (BHC)

Massive debts limit the development and maneuverability of Bausch Health Companies (BHC). Growth is driven by Xifaxan sales and a potential exit from Bausch + Lomb assets. Demand for prescriptions remains stable, but pricing power is constrained by loans. The company's consolidated EBITDA demonstrates current efficiency in an environment of expensive capital, where the latest value is recorded as 4175.48.

Bausch Health Companies (BHC) - Bathi operasional EBITDA saka 23.11.2025 nganti 11.11.2026

Bausch Health (BHC) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:

Rega bursa Bausch Health Corp|BHC - Bagan rega target

- indikator kapitalisasi bursa perusahaan:

Nilai pasar Bausch Health|BHC - Nilai Perusahaan

- rincian valuasi buku bisnis:

Ekuitas saben Saham Bausch Health|BHC - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku bauschhealth.com|BHC - Aset Agregat Perusahaan

- rincian struktur utang lan likuiditas bisnis:

Rasio Utang marang Ekuitas Bausch Health Companies|BHC - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas Bausch Health Companies Inc.|BHC - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Bausch Health|BHC - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Bausch Health|Rasio cepet bauschhealth.com

- indikator bathi lan kelipatan valuasi:

BHC - Bathi resik perusahaan|Prakiraan bathi perusahaan Bausch Health Companies|BHC - Pangali P/E|Prakiraan rega marang bathi bauschhealth.com|BHC - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Bausch Health|BHC - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Bausch Health|BHC - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan bauschhealth.com|BHC - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Bausch Health Companies

Ringkesan analitik perusahaan:Bausch Health Corp (BHC)

This indicator is critical when stress-testing assets to assess a business's ability to service its obligations. The metric measures daily cash flow from core operations before depreciation and taxes; therefore, analyzing operating income before taxes and depreciation allows for the identification of risks regarding the profit degradation of Bausch Health Companies (BHC) amid high debt levels and regulatory pressure in the US.

Karo sapa Bausch Health Companies saingan

Eli Lilly and Co. (LLY) - Bathi sadurunge bunga, pajak, lan amortisasi|ABBV - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|AZN: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|NVS: Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi MRK|NVO (Novo Nordisk Inc.) - Bathi operasional EBITDA|Amgen Inc (AMGN) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Pfizer Inc. (PFE)|sanofi.com - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA BMY (Bristol Myers Squibb)|Bathi operasional sadurunge potongan amortisasi GlaxoSmithKline plc|Takeda Pharmaceutical Company Limited - Bathi operasional EBITDA|TEVA: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|RDY: Bathi operasional EBITDA|viatris.com (VTRS) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi ROIV|Bathi operasional EBITDA Zai Lab Ltd|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Cosmos Holdings (COSM)